These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 11854157)
1. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes. Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157 [TBL] [Abstract][Full Text] [Related]
2. Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome p4501A2. Ueng YF; Kuo YH; Peng HC; Chen TL; Jan WC; Peter Guengerich F; Lin YL Xenobiotica; 2003 Jun; 33(6):603-13. PubMed ID: 12851037 [TBL] [Abstract][Full Text] [Related]
3. Modulation of drug-metabolizing enzymes by extracts of a herbal medicine Evodia rutaecarpa in C57BL/6J mice. Ueng YF; Ko HC; Chen CF; Wang JJ; Chen KT Life Sci; 2002 Aug; 71(11):1267-77. PubMed ID: 12106592 [TBL] [Abstract][Full Text] [Related]
4. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450. Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007 [TBL] [Abstract][Full Text] [Related]
5. Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa. Ueng YF; Wang JJ; Lin LC; Park SS; Chen CF Life Sci; 2001 Nov; 70(2):207-17. PubMed ID: 11787945 [TBL] [Abstract][Full Text] [Related]
6. The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell line. Avery ML; Meek CE; Audus KL Placenta; 2003 Jan; 24(1):45-52. PubMed ID: 12495659 [TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105 [TBL] [Abstract][Full Text] [Related]
8. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Eagling VA; Tjia JF; Back DJ Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822 [TBL] [Abstract][Full Text] [Related]
9. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats. Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Chun YJ; Kim MY; Guengerich FP Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061 [TBL] [Abstract][Full Text] [Related]
11. Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2. Tsyrlov IB; Goldfarb IS; Gelboin HV Arch Biochem Biophys; 1993 Dec; 307(2):259-66. PubMed ID: 8274012 [TBL] [Abstract][Full Text] [Related]
12. Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract. Iwata H; Tezuka Y; Kadota S; Hiratsuka A; Watabe T Drug Metab Pharmacokinet; 2005 Feb; 20(1):34-45. PubMed ID: 15770073 [TBL] [Abstract][Full Text] [Related]
13. Effects of Wu-chu-yu-tang and its component herbs on drug-metabolizing enzymes. Ueng YF; Don MJ; Peng HC; Wang SY; Wang JJ; Chen CF Jpn J Pharmacol; 2002 Jul; 89(3):267-73. PubMed ID: 12184732 [TBL] [Abstract][Full Text] [Related]
14. Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s. Lee SK; Kim NH; Lee J; Kim DH; Lee ES; Choi HG; Chang HW; Jahng Y; Jeong TC Planta Med; 2004 Aug; 70(8):753-7. PubMed ID: 15326550 [TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes. Yao HT; Chang YW; Lan SJ; Yeh TK Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511 [TBL] [Abstract][Full Text] [Related]
16. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro. Chang SY; Chen C; Yang Z; Rodrigues AD Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483 [TBL] [Abstract][Full Text] [Related]
18. Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1. Don MJ; Lewis DF; Wang SY; Tsai MW; Ueng YF Bioorg Med Chem Lett; 2003 Aug; 13(15):2535-8. PubMed ID: 12852960 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Weaver RJ; Thompson S; Smith G; Dickins M; Elcombe CR; Mayer RT; Burke MD Biochem Pharmacol; 1994 Mar; 47(5):763-73. PubMed ID: 8135852 [TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of liver monooxygenases by beta-ionone, 1,8-cineole, (-)-menthol and terpineol. De-Oliveira AC; Fidalgo-Neto AA; Paumgartten FJ Toxicology; 1999 Jul; 135(1):33-41. PubMed ID: 10454222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]